approved glp 1 drugs The FDA has the first GLP-1 pill for weight loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular A new wave of weight-loss
Description
Continued research will be required to examine the long-term safety implications of DPP-4 inhibitors, as well as to discover off-target and congeneric clinical applications in order to fully realize these advantages
Treatment allocation was masked from the participant and investigators and a double check of allocation was performed by an unblinded nurse and pharmacist
Diabetes Care 43 , 634642 (2020)
Nat Rev Gastroenterol Hepatol (2019) 16(6):37786
